Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, March 30, 2020
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
[ Mon, Mar 30th 2020
] - WOPRAI
Fri, March 27, 2020
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
[ Fri, Mar 27th 2020
] - WOPRAI
David Lewis Maintained (AVNS) at Sell with Decreased Target to $29 on, Mar 27th, 2020
David Lewis of Morgan Stanley, Maintained "Avanos Medical, Inc." (AVNS) at Sell with Decreased Target from $32 to $29 on, Mar 27th, 2020.
David has made no other calls on AVNS in the last 4 months.
There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with David's Rating of Hold.
This is the rating of the analyst that currently disagrees with David
- Chris Cooley of "Stephens & Co." Maintained at Buy with Decreased Target to $30 on, Monday, March 23rd, 2020
Similar Stocks and Investing Articles
[ Thu, Mar 26th 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Mon, Mar 23rd 2020
] - WOPRAI
[ Fri, Mar 20th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Tue, Mar 17th 2020
] - WOPRAI
[ Wed, Mar 04th 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Tue, Dec 17th 2019
] - WOPRAI